Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaojiao Li, Qianqian Li, Tianliang Ji, Hong Zhang, Jingrui Liu, Min Wu, Hong Chen, Jinfeng Lou, Chengjiao Liu, Zhongnan Xu & Yanhua Ding. (2022) Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2 receptor antagonist: report of the first-in-human single- and multiple-dose escalation trials in healthy Chinese subjects. Expert Opinion on Investigational Drugs 31:7, pages 729-736.
Read now
Read now
Giancarlo Marone, Maria Rosaria Galdiero, Antonio Pecoraro, Valentina Pucino, Gjada Criscuolo, Maria Triassi & Gilda Varricchi. (2019) Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Expert Opinion on Investigational Drugs 28:1, pages 73-84.
Read now
Read now
Articles from other publishers (27)
Fenghua Qian, Shaneice K. Nettleford, Jiayan Zhou, Brooke E. Arner, Molly A. Hall, Arati Sharma, Charyguly Annageldiyev, Randy M. Rossi, Diwakar B. Tukaramrao, Deborpita Sarkar, Shailaja Hegde, Ujjawal H. Gandhi, Emily R. Finch, Laura Goodfield, Michael D. Quickel, David F. Claxton, Robert F. Paulson & K. Sandeep Prabhu. (2023) Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells. Cell Reports 42:7, pages 112794.
Crossref
Crossref
Yang Yie Sio, Ping Shi, Sri Anusha Matta, Yu Ting Rachel Fok, Wen Chin Chiang, Yee-How Say & Fook Tim Chew. (2023) Functional Polymorphisms of the Arachidonic Acid Pathway Associate with Risks and Clinical Outcomes of Allergic Diseases. International Archives of Allergy and Immunology 184:6, pages 609-623.
Crossref
Crossref
Fangdi ZouYong LiShijie ZhangJian Zhang. (2022)
DP1 (Prostaglandin D
2
Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Induced Hypertension in Mice
. Hypertension 79:6, pages 1203-1215.
Crossref
Crossref
Deping Kong & Ying Yu. (2022) Prostaglandin D2 signaling and cardiovascular homeostasis. Journal of Molecular and Cellular Cardiology 167, pages 97-105.
Crossref
Crossref
Heng LiuR. N. V. Krishna Deepak, Anna Shiriaeva, Cornelius GatiAlexander Batyuk, Hao HuUwe Weierstall, Wei Liu, Lei Wang, Vadim Cherezov, Hao FanCheng Zhang. (2021)
Molecular basis for lipid recognition by the prostaglandin D
2
receptor CRTH2
. Proceedings of the National Academy of Sciences 118:32.
Crossref
Crossref
Xinting Wang, Christian Bartels, Swarupa Kulkarni, Ramachandra Sangana, Monish Jain, Julia Zack & Jing Yu. (2021) Population Pharmacokinetic Analysis of Fevipiprant in Healthy Subjects and Asthma Patients using a Tukey’s g-and-h Distribution. Drug Research 71:06, pages 326-334.
Crossref
Crossref
Yaqun Li, Woong Mo Kim, Seung Hoon Kim, Hyun Eung You, Dong Ho Kang, Hyung Gon Lee, Jeong Il Choi & Myung Ha Yoon. (2021)
Prostaglandin D
2
contributes to cisplatin-induced neuropathic pain in rats
via
DP2 receptor in the spinal cord
. The Korean Journal of Pain 34:1, pages 27-34.
Crossref
Crossref
Milena Sokolowska, G. Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jargen Schwarze, Zuzanna Lukasik, Florentina Sava, Alba Angelina, Oscar Palomares, Cezmi A. Akdis, Liam O’Mahony, Marek Sanak, Sven‐Erik Dahlen & Grzegorz Woszczek. (2021) Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I. Allergy 76:1, pages 114-130.
Crossref
Crossref
Harold M. Aukema. (2021) Prostaglandins as potential targets for the treatment of polycystic kidney disease. Prostaglandins, Leukotrienes and Essential Fatty Acids 164, pages 102220.
Crossref
Crossref
Christopher E Brightling, Mina Gaga, Hiromasa Inoue, Jing Li, Jorge Maspero, Sally Wenzel, Samopriyo Maitra, David Lawrence, Florian Brockhaus, Thomas Lehmann, Caterina Brindicci, Barbara Knorr & Eugene R Bleecker. (2021) Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials. The Lancet Respiratory Medicine 9:1, pages 43-56.
Crossref
Crossref
Corrado Pelaia, Claudia Crimi, Alessandro Vatrella, Maria Teresa Busceti, Achille Gaudio, Eugenio Garofalo, Andrea Bruni, Rosa Terracciano & Girolamo Pelaia. (2020) New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant. Pharmacological Research 155, pages 104490.
Crossref
Crossref
Christopher E. Brightling, Guy Brusselle & Pablo Altman. (2019)
The impact of the prostaglandin D
2
receptor 2 and its downstream effects on the pathophysiology of asthma
. Allergy 75:4, pages 761-768.
Crossref
Crossref
Abdul R. Issahaku, Clement Agoni, Opeyemi S. Soremekun, Patrick A. Kubi, Ransford O. Kumi, Fisayo A. Olotu & Mahmoud E.S. Soliman. (2019) Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma. Combinatorial Chemistry & High Throughput Screening 22:8, pages 521-533.
Crossref
Crossref
Pierachille Santus, Dejan Radovanovic & Davide Alberto Chiumello. (2019) Mucins and Asthma: Are We Headed to the Revolutionary Road?. Journal of Clinical Medicine 8:11, pages 1955.
Crossref
Crossref
Dylan C. Sarver, Kristoffer B. Sugg, Jeffrey R. Talarek, Jacob B. Swanson, David J. Oliver, Aaron C. Hinken, Henning F. Kramer & Christopher L. Mendias. (2019)
Prostaglandin D
2
signaling is not involved in the recovery of rat hind limb tendons from injury
. Physiological Reports 7:22.
Crossref
Crossref
Pierachille Santus, Marina Saad, Giovanni Damiani, Vincenzo Patella & Dejan Radovanovic. (2019) Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers. Pharmacological Research 146, pages 104296.
Crossref
Crossref
Sonja Rittchen & Akos Heinemann. (2019) Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation. Cells 8:6, pages 619.
Crossref
Crossref
Christian Domingo, Oscar Palomares, David A. Sandham, Veit J. Erpenbeck & Pablo Altman. (2018) The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation. Respiratory Research 19:1.
Crossref
Crossref
Angelo Sala, Ewgenij Proschak, Dieter Steinhilber & G. Enrico Rovati. (2018) Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade. Biochemical Pharmacology 158, pages 161-173.
Crossref
Crossref
Lei Wang, Dandan Yao, R.N.V. Krishna Deepak, Heng Liu, Qingpin Xiao, Hao Fan, Weimin Gong, Zhiyi Wei & Cheng Zhang. (2018) Structures of the Human PGD2 Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition. Molecular Cell 72:1, pages 48-59.e4.
Crossref
Crossref
Emily MacLean Scott, Lauren A. Solomon, Courtney Davidson, Jessica Storie, Nami Shrestha Palikhe & Lisa Cameron. (2018) Activation of Th2 cells downregulates CRTh2 through an NFAT1 mediated mechanism. PLOS ONE 13:7, pages e0199156.
Crossref
Crossref
Shengkai Zuo, Deping Kong, Chenyao Wang, Jiao Liu, Yuanyang Wang, Qiangyou Wan, Shuai Yan, Jian Zhang, Juan Tang, Qianqian Zhang, Luheng Lyu, Xin Li, Zhixin Shan, Li Qian, Yujun Shen & Ying Yu. (2018) CRTH2 promotes endoplasmic reticulum stress‐induced cardiomyocyte apoptosis through m‐calpain. EMBO Molecular Medicine 10:3.
Crossref
Crossref
Helle Sadam, Arno Pihlak, Anri Kivil, Susan Pihelgas, Mariliis Jaago, Priit Adler, Jaak Vilo, Olli Vapalahti, Toomas Neuman, Dan Lindholm, Markku Partinen, Antti Vaheri & Kaia Palm. (2018) Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling. EBioMedicine 29, pages 47-59.
Crossref
Crossref
Dejan Radovanovic, Pierachille Santus, Francesco Blasi & Marco Mantero. (2017) The evidence on tiotropium bromide in asthma: from the rationale to the bedside. Multidisciplinary Respiratory Medicine 12:1.
Crossref
Crossref
Katharina Jandl & Akos Heinemann. (2017) The therapeutic potential of CRTH2/DP2 beyond allergy and asthma. Prostaglandins & Other Lipid Mediators 133, pages 42-48.
Crossref
Crossref
Miriam Peinhaupt, Eva M. Sturm & Akos Heinemann. (2017) Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets. Frontiers in Medicine 4.
Crossref
Crossref
Anna Cooper, Sameek Singh, Sarah Hook, Joel D. A. Tyndall & Andrea J. Vernall. (2017) Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors. Pharmacological Reviews 69:3, pages 316-353.
Crossref
Crossref